South Korea
· Delayed Price · Currency is KRW GC Biopharma Company Description
GC Biopharma Corp., a biopharmaceutical company, develops and sells pharmaceutical drugs in South Korea and internationally.
It provides over-the-counter drugs, such as Acustop Cataplasma for Analgesic and anti-inflammatory effect; Kenhancer plaster for anti-inflammatory; and Zenol Cool Type and Zenol Mild Hot Type drugs to treat anti-inflammatory and pain relief.
The company also offers Albumin-GCC injection (inj.) for hypoalbuminemia and shock in acute hemorrhage, as well as low synthesis of albumin; Antithrombin-III (AT-III) inj.
for hereditary antithrombin-III deficiency; Facnyne inj. for hemophilia B; Fibrinogen to treat hypofibrinogenemia and afibrinogenemia; Gamma Globulin for hypogammaglobulinemia and agammaglobulinemia; GCFLU Quadrivalent and GC FLU pre-filled syringe inj.
for prevention of influenza; GreenGene F inj. for bleeding symptom control and hemostasis for persons with hemophilia A; GreenGene inj.
for bleeding episodes induced by hemophilia A; Greenplast Q for sealing tissues and closing open wounds; and Green-VIII inj.
for Hemophilia A with supplies of blood coagulation factor VIII. In addition, it provides Hepabig inj.
for hepatitis B; Histobulin to treat bronchial asthma; Hunterase for hunter syndrome; I.V. Hepabig inj.
for prevention of hepatitis B recurrence in patients following liver transplantation; I.V.-Globulin SN inj.
5%; Immuncell-LC to treat liver cancer; Sero-Tet inj. for prophylaxis of tetanus and the reduction of tetanus symptoms; Shinbaro for anti-inflammation, pain relief, and osteoarthritis; Varicella Vaccine-GCC inj.
for prophylaxis of varicella; and Varicella-Zoster Immune Globulin-GCC inj. for passive immunity to susceptible immunodeficient children exposed to varicella.
It has a research and development agreement with Novelty Nobility to develop antibody-based therapeutics for geographic atrophy.
The company was founded in 1967 and is headquartered in Yongin-Si, South Korea. GC Biopharma Corp. is a subsidiary of Green Cross Holdings Corporation.
| Country | South Korea |
| Founded | 1967 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 2,009 |
| CEO | Il-Sup Huh |
Contact Details
Address: 107, Ihyeon-ro 30beon-gil Yongin-Si South Korea | |
| Phone | 82 3 1260 9300 |
| Website | globalgreencross.com |
Stock Details
| Ticker Symbol | 006280 |
| Exchange | Korea Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| ISIN Number | KR7006280002 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Il-Sup Huh Ph.D. | Chairman and Chief Executive Officer |
| Eun-Cheol Hur | President and Director |
| Min-Taek Lee | Senior Managing Director of Sales |
| Young Sup Huh | Executive Vice President |
| In-Jae Lee | Senior MD and Director |
| Byeong-Hwa Kim | Vice President and Director |